scholarly journals Evaluation of unfractionated heparin versus low-molecular-weight heparin and fondaparinux for pharmacologic venous thromboembolic prophylaxis in critically ill patients with cancer

2018 ◽  
Vol 16 (12) ◽  
pp. 2492-2500 ◽  
Author(s):  
E. T. Van Matre ◽  
P. M. Reynolds ◽  
R. MacLaren ◽  
S. W. Mueller ◽  
G. C. Wright ◽  
...  
Keyword(s):  
Molecular Weight ◽  
Unfractionated Heparin ◽  
Critically Ill ◽  
Critically Ill Patients ◽  
Low Molecular Weight Heparin ◽  
Low Molecular Weight ◽  
Thromboembolic Prophylaxis ◽  
Patients With Cancer ◽  
Venous Thromboembolic

scholarly journals Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial

PLoS ONE ◽  
2018 ◽  
Vol 13 (6) ◽  
pp. e0198285 ◽  
Author(s):  
Menaka Pai ◽  
Neill K. J. Adhikari ◽  
Marlies Ostermann ◽  
Diane Heels-Ansdell ◽  
James D. Douketis ◽  
...  
Keyword(s):  
Molecular Weight ◽  
Renal Dysfunction ◽  
Critically Ill ◽  
Subgroup Analysis ◽  
Critically Ill Patients ◽  
Low Molecular Weight Heparin ◽  
Low Molecular Weight
Sign in / Sign up

Export Citation Format

Share Document